Luminex Signs Distribution Deal With Bio-Techne | GenomeWeb

NEW YORK (GenomeWeb) – Luminex today announced it has signed a distribution and supply agreement with Bio-Techne that will last through 2020.

Under the terms of the agreement, Bio-Techne will distribute Luminex instruments, including the Luminex 200, Flexmap 3D, and Magpix, in major markets worldwide. Bio-Techne will also continue to develop and commercialize immunoassays for the Luminex platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.